Free release
1,3,6,7-Tetrahydroxy-4-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)

1,3,6,7-Tetrahydroxy-4-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)

CAS No. :24699-16-9MDL No. :MFCD00238624Formula :C19H18O11Boiling Point :-Linear Structure Formula :-InChI Key :CDYBOKJA

Sales:Service@apichina.com
CAS No. :24699-16-9 Brand :Qitai
Formula :C19H18O11 M.W :422.34

Introduction

CAS No. :24699-16-9 MDL No. :MFCD00238624
Formula : C19H18O11 Boiling Point : -
Linear Structure Formula :- InChI Key :CDYBOKJASDEORM-HBVDJMOISA-N
M.W : 422.34 Pubchem ID :5318597
Synonyms :
Chemical Name :1,3,6,7-Tetrahydroxy-4-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9H-xanthen-9-one

Physicochemical Properties

Num. heavy atoms : 30
Num. arom. heavy atoms : 14
Fraction Csp3 : 0.32
Num. rotatable bonds : 2
Num. H-bond acceptors : 11.0
Num. H-bond donors : 8.0
Molar Refractivity : 100.7
TPSA : 201.28 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -9.14 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.08
Log Po/w (XLOGP3) : -0.37
Log Po/w (WLOGP) : -1.04
Log Po/w (MLOGP) : -2.66
Log Po/w (SILICOS-IT) : -0.68
Consensus Log Po/w : -0.73

Druglikeness

Lipinski : 2.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 3.0
Bioavailability Score : 0.17

Water Solubility

Log S (ESOL) : -2.44
Solubility : 1.54 mg/ml ; 0.00364 mol/l
Class : Soluble
Log S (Ali) : -3.39
Solubility : 0.17 mg/ml ; 0.000404 mol/l
Class : Soluble
Log S (SILICOS-IT) : -0.97
Solubility : 45.2 mg/ml ; 0.107 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.9
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: